Dr Reddys Laboratories (RDY) Debt Ratio (2009 - 2026)
Dr Reddys Laboratories' Debt Ratio came in at 0.13 for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 16.5% from 0.11 a year earlier but down 2.6% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Debt Ratio (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Dr Reddys Laboratories reported Debt Ratio of 0.53, up 32.7% year-over-year.
- Debt Ratio has increased in each of the last three fiscal years.
- Going back by fiscal year, Debt Ratio was 0.09 in FY2025 (+82.9%), 0.05 in FY2024 (+23.8%), 0.04 in FY2023 (-63.8%) and 0.12 in FY2022 (+1.3%).
- The five-year range for quarterly Debt Ratio is 0.04 (fiscal Q1 2024) to 0.13 (fiscal Q4 2026).
- Year-over-year, Debt Ratio has increased for 11 consecutive quarters, with growth averaging 39.4% over the last eight quarters.
- The fastest year-over-year change in Debt Ratio over five years came in fiscal Q2 2025 (growth of 148.0%), and the weakest in fiscal Q4 2023 (a decline of 63.8%).
- Business Quant data shows RDY's Debt Ratio at 0.13 (Q1 2027), 0.13 (Q4 2026) and 0.13 (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 0.33 |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 0.23 |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 0.55 |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 0.41 |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -0.10 |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 0.56 |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 0.51 |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 0.31 |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 0.13 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.13 |
| Jun 30, 2026 | 0.13 |
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.11 |
| Jun 30, 2025 | 0.10 |
| Mar 31, 2025 | 0.09 |
| Dec 31, 2024 | 0.11 |
| Sep 30, 2024 | 0.10 |
| Jun 30, 2024 | 0.08 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | 0.04 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | 0.08 |
| Jun 30, 2022 | 0.10 |
| Mar 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.10 |
API Access
Dr Reddys Laboratories Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();